naltrexone has been researched along with Bile Duct Obstruction, Extrahepatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbasi, A; Dehpour, AR; Faramarzi, N; Mazouchi, M; Tavangar, SM | 1 |
| Dehpour, AR; Ebrahimkhani, MR; Ghaffari, K; Honar, H; Moezi, L; Riazi, K; Savadkuhi, ST; Shafaroodi, H; Tahmasebi, MS | 1 |
2 other study(ies) available for naltrexone and Bile Duct Obstruction, Extrahepatic
| Article | Year |
|---|---|
Opioid receptor antagonist promotes angiogenesis in bile duct ligated rats.
Topics: Angiogenesis Inducing Agents; Animals; Cholestasis, Extrahepatic; Common Bile Duct; Disease Models, Animal; Ligation; Male; Microvessels; Naltrexone; Narcotic Antagonists; Neovascularization, Physiologic; Opioid Peptides; Rats; Rats, Sprague-Dawley; Receptors, Opioid | 2009 |
Obstructive cholestasis alters intestinal transit in mice: role of opioid system.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Cholestasis, Extrahepatic; Disease Models, Animal; Drug Therapy, Combination; Gastrointestinal Transit; Injections, Intraperitoneal; Injections, Subcutaneous; Intestine, Small; Male; Mice; Mice, Inbred Strains; Morphine; Naltrexone | 2004 |